Quantitative Renal Uptake Using TC99m DMSA in Hypertensive &/or Diabetic Patients.
Phase 4
- Conditions
- Diabetes MellitusHypertension
- Interventions
- Diagnostic Test: DMSA scan
- Registration Number
- NCT03123237
- Lead Sponsor
- Assiut University
- Brief Summary
the investigators explore the possible role of DMSA to detect renal affection in diabetic \&/or hypertensive patients by detecting difference in counts using Tc 99m DMSA in control \& diabetic \&/or hypertensive patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 45
Inclusion Criteria
-
• Patients with diabetes (type2), weather controlled or not.
- Patients with essential hypertension.
- Patients with diabetes & hypertension.
- Within normal renal function (urea & creatinine).
- Control cases may be normal individuals (apparently healthy) like donors for renal transplant.
Exclusion Criteria
-
• Patients with abnormal renal function.
- Patients with diseases known to affect kidney function rather diabetes & hypertension e.g. SLE, heart failure or liver cell failure.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Control DMSA scan control will be subjected to: • Quantitative Tc99m DMSA renal scan using SPECT technique. Diabetic & Hypertensive DMSA scan Diabetic \& Hypertensive cases will be subjected to: • Quantitative Tc99m DMSA renal scan using SPECT technique. Diabetic DMSA scan diabetic cases will be subjected to: • Quantitative Tc99m DMSA renal scan using SPECT technique. Hypertensive DMSA scan hypertesive cases will be subjected to: • Quantitative Tc99m DMSA renal scan using SPECT technique.
- Primary Outcome Measures
Name Time Method Renal Counts 2-4 hours Quantitative Tc99m DMSA renal scan using SPECT technique will be used to measure renal function.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Assiut university
🇪🇬Assiut, Egypt